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Abstract
Background: Group B streptococcus (GBS), which asymptomatically colonises the vaginal and rectal
areas of women, is the leading cause of septicemia, meningitis and pneumonia in neonates. In Tanzania no
studies have been done on GBS colonisation of pregnant women and neonates. This study was conducted
in Dar es Salaam, Tanzania to determine the prevalence of GBS colonisation among pregnant women, the
neonatal colonisation rate and the antimicrobial susceptibility, thus providing essential information to
formulate a policy for treatment and prevention regarding perinatal GBS diseases.
Methods: This cross sectional study involved 300 pregnant women attending antenatal clinic and their
newborns delivered at Muhimbili National Hospital (MNH) between October 2008 and March 2009. High
vaginal, rectal, nasal, ear and umbilical swabs were cultured on Todd Hewitt Broth and in 5% sheep blood
agar followed by identification of isolates using conventional methods and testing for their susceptibility to
antimicrobial agents using the Kirby-Bauer method.
Results: GBS colonisation was confirmed in 23% of pregnant women and 8.9% of neonates. A higher
proportion of GBS were isolated from the vagina (12.3%) as compared to the rectum (5%). Prolonged
duration of labour (>12 hrs) was significantly shown to influence GBS colonisation in neonates P < 0.05.
Other risk factors such as prolonged rupture of membrane, intrapartum fever, low birth weight and HIV
infection did not correlate with GBS colonisation. All isolates were sensitive to vancomycin and ampicillin.
Resistance to clindamycin, erythromycin and penicillin G was found to 17.6%, 13% and 9.4%, respectively.
Conclusion: Our findings seem to suggest that a quarter of pregnant women attending ANC clinic at
MNH and approximately 10% of their newborns are colonised with GBS. All isolates were found to be
sensitive to vancomycin and ampicillin which seem to be the most effective antibiotics for the time being.
However there is a need for continuous antibiotics surveillance of GBS to monitor trend of resistance.
The high isolation frequency of GBS among pregnant women suggests routine antenatal screening at 35 to
37 weeks of gestation in order to provide antibiotic prophylaxis to GBS carrier.
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Background
Group B Streptococcus (GBS) is now recognized to be an
important cause of maternal and neonatal morbidity and
mortality in many parts of the world [1,2]. GBS infections
tend to occur more commonly among adults than in
neonates, but the overall mortality is higher in neonates
[3]. Risk of disease is greater in pregnant women than in
men and non-pregnant women. At birth, infants who are
born to colonized mothers may also become colonised on
their mucosal surfaces such as oral, nasopharynx, vaginal
and anal mucosa and skin [4]. Approximately 60% of
infants born to colonised mother become colonised with
their mother's organisms [3]. The likelihood of neonatal
colonisation at birth is higher if the mother is heavily col-
onised [3].
GBS infection is the leading cause of perinatal bacterial
infection [5], being commonly responsible for septicemia,
meningitis and pneumonia in neonates. However, the
burden of perinatal GBS disease varies between countries.
Intrapartum antimicrobial prophylaxis to GBS carriers has
been reported to be effective in reducing GBS disease. Pre-
vention guidelines for perinatal GBS disease were issued
by Centers for Disease Control and Prevention (CDC) in
1996, and revised in 2002 [6,7]. Since its introduction, the
incidence of early-onset neonatal infections has decreased
by 62% [7].
In Tanzania, as is the case in several other sub-Saharan
countries in Africa, the rate of GBS colonisation among
pregnant women and neonates has not been studied and
therefore to date no strategies have been formulated to
prevent neonatal GBS infection in the country. Thus the
aims of this study was to determine the prevalence and
risk factors of maternal and neonatal colonisation with
GBS at Muhumbili National Hospital (MNH), Dar es
Salaam Tanzania in order to generate local data that will
inform the development of rational interventions for GBS
infection and disease.
Methods
Study design and setting
This was a hospital based cross-sectional study conducted
at Muhimbili National Hospital (MNH), Dar es Salaam,
Tanzania between October 2008 and March 2009. MNH
is a tertiary facility which handles referrals from periph-
eral and upcountry hospitals.
Study population
The study included 300 third trimester pregnant women
(from 37 weeks of gestation) attending the antenatal clin-
ics at MNH for routine antenatal visits and their neonates
(180) delivered at the MNH labor ward. Sample size was
calculated from the following formula n = z2p (100-p)/e2
where p, in the absence of local data, was taken as the
median prevalence of GBS carriage among pregnant
women in African countries (16%) [8,9]. All consenting
mothers with gestation age ≥ 37 weeks were included. Par-
ticipants with history of using antibiotic(s) within two
weeks prior to recruitment were excluded from the study.
Data collection
Data was collected after obtaining written informed con-
sent using a standard structured questionnaire designed to
obtain social demographic data and other relevant infor-
mation such as maternal age, gestational age, previous
obstetric history, history of current pregnancy, parity,
marital status, mode of delivery, administration of antibi-
otics during labor and neonate's birth weight. Pregnant
women were interviewed at 37 weeks of gestation, during
labour and after delivery.
Specimen collection and transport
High vaginal and rectal swabs were collected at 37 weeks
of gestation using sterile swab stick. In addition, umbilical
swabs, ear canal and nasal swabs were collected from
neonates within one hour after delivery. The swabs were
inoculated directly into Todd Hewitt Broth (Oxoid Ltd)
and transported to the central pathology laboratory of the
MNH for processing within 2 hours of collection. About
three millilitres of venous blood were drawn aseptically
into sterile vacutainer tubes (BD NJ USA) without antico-
agulant for detection of HIV antibodies and in EDTA (BD
NJ USA) vacutainer tubes for quantification of CD4+T
lymphocytes counts.
Laboratory Procedures
The swabs were inoculated in Todd-Hewitt broth (Oxoid
Ltd) containing nalidixic acid (15 mg/L) and gentamicin
(8 mg/L) and incubated at 37°C in 5% Co2 for 24 h. Sub-
cultures were performed in 5% sheep blood agar for isola-
tion of GBS. Broth cultures showing no visible turbidity
after overnight incubation were further re-incubated and
then sub cultured after 48 hours on sheep blood agar. Pre-
sumptive identification of GBS was made by traditional
physiological and biochemical methods. These included
Gram stain, catalase reaction, hemolytic activity on sheep
blood agar plates, hippurate and CAMP tests. Confirma-
tive identification of Group B Streptococcus was done
using Streptex- agglutination test (Remel Europe Ltd).
Finally, antimicrobial susceptibility of all GBS isolates was
determined by Kirby-Bauer disk diffusion method accord-
ing to Clinical Laboratory Standard Institute (formerly
NCCLS). The antimicrobials included; penicillin G (10
U), ampicillin (10 μg), clindamycin (2 μg.), erythromycin
(15 μg), vancomycin (30 μg), ciprofloxacin (5 μg), ceftri-
axone (30 μg) and co-trimoxazole 25 μg.  S. agalactiae
ATCC 27956 was used as a control organism.BMC Public Health 2009, 9:437 http://www.biomedcentral.com/1471-2458/9/437
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HIV screening
HIV testing was done using Tanzania's National HIV rapid
test algorithm [10]. SD-Bioline HIV 1/2 (SD Standard
Diagnostic, Inc Korea) was used for initial screening and
reactive samples were confirmed by Determine™ (Abbott
Laboratory, Tokyo Japan). A sample was considered
seronegative if it was non reactive at screening and serop-
ositive when reactive on both assays. There were no dis-
cordant samples.
CD4+ T lymphocytes enumeration
This was determined by using Becton Dickson FACS Cali-
bur flow cytometry.
Data analysis
Data was analysed using SPSS for windows version 13.0
[11]. Comparison of proportions of maternal and neona-
tal colonisation of GBS and statistical significance of GBS
in HIV infected and non HIV infected pregnant women
colonised with GBS were tested by using the Pearson's
Chi-squared test (χ2). Where the numbers in a cell was less
than five, a Fisher's exact test was used. P-values ≤ 0.05
were considered statistically significant.
Ethical issues
Ethical and research clearance was obtained from Muhim-
bili University of Health and Allied Sciences (MUHAS)
Senate Research and Publication Committee. A written
informed consent was obtained from each participant
prior to enrolment. HIV- pre and post test counselling
were provided to the participants according to the Tanza-
nia national guidelines for HIV testing and counselling
[12]. Any other requested additional information was
provided to participants by study personnel. HIV positive
women were offered prevention of mother to child trans-
mission (PMTCT) services and also referred to HIV care
and treatment clinic within MNH for further manage-
ment, according to the National guidelines for Care and
Treatment, Ministry of Health, Tanzania. GBS results of
neonates were relayed to attending doctors for their man-
agement. All participants' results were kept confidentially.
Results
Three hundred pregnant women (from 37 weeks of gesta-
tion) and 180 neonates were enrolled in the study
between October and March 2009. There was loss of fol-
low up of 120 neonates, due to the fact that not all preg-
nant women delivered at MNH. GBS were isolated from
69 (23%) pregnant women and from16 (8.9%) neonates.
Vaginal carriage rate was higher 37 (12.3%) than rectal
colonisation rate 15(5%). The proportion of GBS isolated
from both sites was 17(5.7%).
Table 1 summarises the rate of GBS colonisation by social
demographic characteristics. The age of the women
ranged from 16-44 years with mean age of 26.6 years (SD
± 5.1). Generally, GBS colonisation did not appear to be
influenced by maternal age, marital status, education level
Table 1: Association between social demographic factors and GBS colonisation among pregnant women




<20 26 4 15.4
20-24 86 19 22.1
25-29 107 23 21.5 0.43
30-34 56 18 32.1
>35 25 5 20
Marital status
Single 52 10 19.2
Married/Cohabiting 244 58 23.8 0.74
Divorced 3 1 33.3
Widow 1 0 0
Education level
None 8 3 37.5
Primary 145 30 20.7 0.54
Secondary 104 28 26.0




279 65 23.3 0.65
Multiple 21 4 19BMC Public Health 2009, 9:437 http://www.biomedcentral.com/1471-2458/9/437
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or number of sexual partners. The study revealed a higher
colonisation rate among the age group 30-34 years
(32.1%) but lower (15.4%) in women aged less than 20
years, however the difference was not statistically signifi-
cant (P > 0.05). GBS colonisation was also more prevalent
among women with no formal education when compared
with those with secondary education, post secondary and
primary education however this was not statistically sig-
nificant (P > 0.05). Of the 300 women investigated, the
majority (93%) reported having one sexual partner while
21(7%) had multiple sexual partners in the last one year
preceding the study. GBS colonisation did not differ sig-
nificantly with marital status, being 33.3% among
divorced women, 23.8% among married and 19.3%
among single women (P > 0.05).
Table 2 shows maternal obstetric factors and HIV status in
relation to GBS colonisation. Women with gestation age
between 41 and 42 weeks were found to have significantly
higher colonisation rate (46.7%), followed by those with
gestational ages of 37-38 weeks (23.6%) and 39-40 weeks
(15.4%), P < 0.05. The parity ranged from zero to seven
with parity mean of 0.88. Colonisation rate was higher
(50%) in women who had delivered four or more times
and lower in women who had delivered once (19.8%).
However, this difference was not statistically significant (P
> 0.05).
Women with previous history of stillbirth had higher rate
(28.6%) of GBS colonisation followed by those with nor-
mal previous obstetric history (23.2%) and with history of
spontaneous abortion (11.1%) (P > 0.05). No GBS colo-
nisation was observed in women with previous history of
premature labour. Sixty four (23.4%) of the women with
GBS colonisation had no history of dysuria. In this study
urine culture was not done in patients with dysuria.
HIV infection was detected in 24/300 (8%) of the study
population, among whom 2/24 (8.3%) had GBS coloni-
sation (P > 0.05) and one had CD4 T-cell count less than
200 cells/μL and the other had CD4 T-cell count above
200 cells/μl.





37-38 220 52 23.6
39-40 65 10 15.4 0.03
41-42 15 7 46.7
Parity
01 3 8 3 3 2 3 . 9
19 1 1 8 1 9 . 8
2 51 11 21.6 0.45
31 2 3 2 5
46 3 5 0
≥ 52 1 5 0
Previous obstetric history
Normal healthy baby 137 32 23.2 0.44
Premature 6 0 0
Spontaneous abortion 18 2 11.1
Stillbirth 14 4 28.6
Dysuria
No 273 64 23.4
Yes 27 5 18.5 0.38
Vaginal discharge
No 284 66 23.2 0.67
Yes 16 3 18.8
HIV infection
No 276 67 24.3 0.08
Yes 24 2 8.3
*125 out of 300 pregnant women were primigravida and had no previous obstetric history.BMC Public Health 2009, 9:437 http://www.biomedcentral.com/1471-2458/9/437
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The association between GBS colonisation rate in
neonates and maternal obstetric factors is summarized in
Table 3. Prolonged duration of labour was significantly
shown to influence GBS colonisation in neonates; 6/17
(35.3%), P < 0.001. The rate of GBS colonisation was
higher 14/139 (10.1%) in neonates born by spontaneous
vaginal delivery compared to 2/41 (4.9%) among
neonates born by caesarean section, P > 0.05 however,
was not statistically significant. Nearly all women (15/16)
who had history of taking antibiotic during labour had
neonates with no GBS colonisation. The time taken
between antibiotic intake and delivery was approximately
one to four hours for those who were given intravenous
antibiotics (ampicillin or ceftriaxone) at labour ward. The
reasons for antibiotic administration included; prolonged
duration of labor with fetal distress, caesarean section,
and intrapartum fever.
Table 4 presents the antimicrobial susceptibility pattern of
GBS isolated from different sites. The GBS isolates were all
(100%) sensitive to vancomycin and ampicillin, (90%-
100%) sensitive to penicillin G and ciprofloxacin and
(80-90%) sensitive to clindamycin, erythromycin, cotri-
moxazole and ceftriaxone.
Discussion
This study at the MNH in Dar es Salaam, Tanzania shows
the overall prevalence of GBS among pregnant women
and neonates to be 23% and 8.9%, respectively. These
findings are consistent with reports from other developing
countries [8,13], but lower than those reported in Zimba-
bwe 31.6% and Trinidad 32.9% [9,14], indicating signifi-
cant country variations [15]. The variations between
countries could possibly be due, at least in part, to differ-
ences in sampling sites and techniques. For instance, in
this study due to investigating sexually transmitted infec-
tions, we used high vaginal swabs which is in keeping
with some previous studies [9,16], while others investiga-
tors have used lower third of vaginal site [5,6]. Other var-
iations in isolation frequency could be due differences in
culture methods, and type of culture media used as well as
populations investigated [4].
In this study vaginal carriage rate (12.3%) was higher than
rectal colonisation rate (5%), which is comparable to a
study done in Zimbabwe by Moyo et al [13] in which vag-
inal and rectal colonisation rates were 12.6% and 6.3%,
respectively. The fact that GBS was at times isolated from
one and not the other site clearly indicate that it is impor-
tant to sample both vagina and rectum when screening for
GBS carriage in pregnant women.
Notably, there was loss of 120 neonates to follow up due
to the fact that mothers delivered in other facilities. One
twenty neonates made 40% of neonates and this could
have affected the reported neonatal colonisation rate.




Mode of delivery Vaginal delivery 139 14 10.1
Caesarean 41 2 4.9 0.61
Time of membrane rupture 178 16 9 0.65
≤ 18 hrs 2 0 0
>18 hrs
Intrapartum fever
No 177 16 9 0.58
Yes 3 0 0
Antibiotic use before/during labour
No 164 15 9.1 0.69
Yes 16 1 6.3
Duration of labour
≤ 12 hrs 163 10 6.1 0.00
>12 hrs 17 6 35.3
Weight of baby
<2.5 kg 20 1 5 0.51
≥ 2.5 kg 160 15 9.4BMC Public Health 2009, 9:437 http://www.biomedcentral.com/1471-2458/9/437
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Samples cultured from mothers and neonates showed
that 37% of the pairs had positive GBS culture results,
which is in keeping with other studies reporting transmis-
sion rates ranging from 29% to 85% [17,18].
Of all the factors investigated, maternal colonisation was
significantly higher in women of gestation age between 41
and 42 weeks compared to women of gestation age
between 39 and 40 weeks, indicating an increase GBS car-
riage with gestation age. The other maternal factors
including social demographic factors were not signifi-
cantly associated with GBS colonisation.
In the present study GBS was isolated more frequently
from women of age group 30-34 (32.1%) compared with
women aged <20 years (15.4%), which is in contrast with
reports from another study showing high isolation fre-
quencies in women younger than 20 years [1]. These dif-
ferences are difficult to explain but possibly underscore
the fact that GBS colonisation might be influenced by
multiple factors which may vary from one geographical
location to another.
This study revealed that women with no formal education
(34.8%) were more likely to be colonised with GBS, a
finding that is consistent with observations by Regan et al
[19]. The association could be partly explained by the dif-
ference in personal hygiene, which is more likely to be
better among educated than the less educated women.
GBS colonisation in the studied population was not asso-
ciated with either HIV infection or CD4+ T cell count,
probably due to the small sample of HIV infected preg-
nant women among the studied population and the fact
that only one woman had CD4 counts < 200 cells/μl.
Of all possible factors for GBS colonisation in neonates
that were investigated only prolonged duration of labour
showed significant association, P < 0.001, probably due to
prolonged exposure of the neonate in the birth canal. The
strong association between prolonged labour and GBS
colonisation calls for routine antibiotic prophylaxis in
such women in order to decrease the chances of subse-
quent neonatal infection.
Other risk factors such as prolonged rupture of mem-
brane, intrapartum fever, mode of delivery and low birth
weight did not influence GBS colonisation in neonates.
The lack of association with these factors can possibly be
explained by the fact that the numbers of participants in
this study with such risk factors were small (2%). We did
not investigate the timing of caesarean section in relation
to prelabor and post labour rupture of membrane versus
spontaneous vaginal delivery, which could be viewed as
one of the limitations of the study. However, the small
number of women who delivered by caesarean section
may not show any potential association.
Notably all GBS isolated were sensitive to ampicillin and
vancomycin, implying that these two antibiotics could be
used for empiric prophylaxis. Most isolates (90% to 98%)
were sensitive to ciprofloxacin and penicillin G and (80%
to 90%) sensitive to clindamycin, erythromycin and
ceftriaxone indicating the current value of these different
antibiotics in the treatment and prophylaxis of GBS infec-
tion in Dar es Salaam.
Conclusion
The high prevalence of GBS colonisation among pregnant
women and neonates calls for screening of this bacterium
in women attending antenatal care so that intrapartum
antimicrobial prophylaxis can be offered to all women
identified as carriers.
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